Roderick Flower
Corporate Officer/Principal bei St. Bartholomew's Hospital
Vermögen: 62 021 $ am 31.03.2024
Profil
Roderick J.
Flower is the founder of William Harvey Research Institute.
He currently holds the position of Professor at St. Bartholomew's Hospital, Professor at St Bartholomew's Hospital Medical College, and Professor-Emeritus at Queen Mary University of London.
Previously, he served as an Independent Director at Antibe Therapeutics, Inc. from 2013 to 2024.
He also held the positions of President at the Academy of Medical Sciences, President at the British Pharmacological Society, and President at the Society of Biology.
Dr. Flower obtained a doctorate degree from the University of London and an undergraduate degree from The University of Sheffield.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 11.01.2024 | 185 136 ( 0,35% ) | 62 021 $ | 31.03.2024 |
Aktive Positionen von Roderick Flower
| Unternehmen | Position | Beginn |
|---|---|---|
| St. Bartholomew's Hospital | Corporate Officer/Principal | - |
| St Bartholomew's Hospital Medical College | Corporate Officer/Principal | - |
| Queen Mary University of London | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Roderick Flower
| Unternehmen | Position | Ende |
|---|---|---|
| ANTIBE THERAPEUTICS INC. | Director/Board Member | 24.04.2024 |
William Harvey Research Institute
 William Harvey Research Institute Other Consumer ServicesConsumer Services The William Harvey Research Institute is a research institute that focuses on innovation of therapeutic treatments for cardiovascular and inflammatory diseases. Flower. The British company was founded by Roderick J. | Founder | 01.01.2004 |
British Pharmacological Society
 British Pharmacological Society Investment Trusts/Mutual FundsMiscellaneous The British Pharmacological Society is a charity and membership organization that aims to promote and advance the field of pharmacology. The private company is based in London, UK. The British company leads the way in researching and applying pharmacology worldwide. The company was founded in 1931. Rachel Lambert-Forsyth has been the CEO of the company since 2020. | President | - |
| Society of Biology | President | - |
Academy of Medical Sciences
 Academy of Medical Sciences Miscellaneous Commercial ServicesCommercial Services The Academy of Medical Sciences was founded in 1998 and provides biomedical and health research services. The non-profit company is based in London, UK. | President | - |
Ausbildung von Roderick Flower
| University of London | Doctorate Degree |
| The University of Sheffield | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 6 |
|---|---|
| St. Bartholomew's Hospital | |
Academy of Medical Sciences
Academy of Medical Sciences Miscellaneous Commercial ServicesCommercial Services The Academy of Medical Sciences was founded in 1998 and provides biomedical and health research services. The non-profit company is based in London, UK. | Commercial Services |
William Harvey Research Institute
William Harvey Research Institute Other Consumer ServicesConsumer Services The William Harvey Research Institute is a research institute that focuses on innovation of therapeutic treatments for cardiovascular and inflammatory diseases. Flower. The British company was founded by Roderick J. | Consumer Services |
British Pharmacological Society
British Pharmacological Society Investment Trusts/Mutual FundsMiscellaneous The British Pharmacological Society is a charity and membership organization that aims to promote and advance the field of pharmacology. The private company is based in London, UK. The British company leads the way in researching and applying pharmacology worldwide. The company was founded in 1931. Rachel Lambert-Forsyth has been the CEO of the company since 2020. | Miscellaneous |
| Society of Biology | |
| Antibe Therapeutics, Inc. |
